Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Pierre Préziosi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Vaccine|April 23, 2003
Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousnessMarie-Pierre Préziosi, M Elizabeth Halloran
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2003
Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severityMarie-Pierre Préziosi, M Elizabeth Halloran
Statistics in Medicine|December 26, 2003
Estimating heterogeneous transmission with multiple infectives using MCMC methodsHaitao Chu, Marie-Pierre Préziosi, M Elizabeth Halloran
Vaccine|May 25, 2007
The Meningitis Vaccine ProjectF Marc LaForce, Kader Konde, Simonetta Viviani, et al.
American Journal of Epidemiology|May 8, 2002
Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination programMarie-Pierre Préziosi, Abdoulaye Yam, Steven G F Wassilak, et al.
The Lancet. Infectious Diseases|May 27, 2017
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance dataCaroline L Trotter, Clément Lingani, Katya Fernandez, et al.
BMC Infectious Diseases|November 6, 2016
Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccineGuro K Bårnes, Paul A Kristiansen, Demissew Beyene, et al.
Vaccine|May 29, 2007
Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adultsNilima Kshirsagar, Naidu Mur, Urmila Thatte, et al.
BMC Infectious Diseases|December 5, 2014
Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVacPaul A Kristiansen, Absatou Ky Ba, Abdoul-Salam Ouédraogo, et al.
Journal of Clinical Microbiology|October 5, 2012
Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterizationPaul A Kristiansen, Fabien Diomandé, Rasmata Ouédraogo, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Vaccine|April 23, 2003
Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousnessMarie-Pierre Préziosi, M Elizabeth Halloran
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2003
Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severityMarie-Pierre Préziosi, M Elizabeth Halloran
Statistics in Medicine|December 26, 2003
Estimating heterogeneous transmission with multiple infectives using MCMC methodsHaitao Chu, Marie-Pierre Préziosi, M Elizabeth Halloran
Vaccine|May 25, 2007
The Meningitis Vaccine ProjectF Marc LaForce, Kader Konde, Simonetta Viviani, et al.
American Journal of Epidemiology|May 8, 2002
Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination programMarie-Pierre Préziosi, Abdoulaye Yam, Steven G F Wassilak, et al.
The Lancet. Infectious Diseases|May 27, 2017
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance dataCaroline L Trotter, Clément Lingani, Katya Fernandez, et al.
BMC Infectious Diseases|November 6, 2016
Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccineGuro K Bårnes, Paul A Kristiansen, Demissew Beyene, et al.
Vaccine|May 29, 2007
Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adultsNilima Kshirsagar, Naidu Mur, Urmila Thatte, et al.
BMC Infectious Diseases|December 5, 2014
Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVacPaul A Kristiansen, Absatou Ky Ba, Abdoul-Salam Ouédraogo, et al.
Journal of Clinical Microbiology|October 5, 2012
Carriage of Neisseria lactamica in 1- to 29-year-old people in Burkina Faso: epidemiology and molecular characterizationPaul A Kristiansen, Fabien Diomandé, Rasmata Ouédraogo, et al.
Pageof 2